Clinical Trial Update: Ides in Highly Sensitized (HS) Patients Awaiting Kidney Transplantation [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for ides in highly sensitized patients awaiting kidney transplantation; completed Phase 1/Phase 2 study with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Disease
• Renal Disease

Snippet

Sponsor: Cedars-Sinai Medical Center | Conditions: Renal Disease | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-05-16